Zhongxia Yang
Lanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Immune checkpoint inhibitors in POLE/POLD1 proofreading-deficient CRC: from molecular basis to clinical practice and future directions.
Journal: Immunotherapy
Published: April 22, 2026
Annexin A5 ameliorates immune-mediated liver injury by regulating ferritinophagy-ferroptosis in M2 macrophages via the NRF2/ERK pathway.
Journal: Cellular signalling
Published: August 31, 2025
Case Report: Infection with Streptococcus constellatus manifesting as gelatinous pleural effusion in an HIV-positive patient.
Journal: Frontiers in immunology
Published: December 14, 2024
Disulfiram alleviates immune-mediated liver injury by inhibiting pyroptosis in hepatocytes through the NF-κB pathway.
Journal: European journal of pharmacology
Published: September 23, 2024
Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer.
Journal: Therapeutic advances in gastroenterology
Published: November 03, 2016
Inhibitors of PARP-1 exert inhibitory effects on the biological characteristics of hepatocellular carcinoma cells in vitro.
Journal: Molecular medicine reports
Published: February 28, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026